OMG
Summary:
Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
---|---|---|---|---|---|
oligodendrocyte myelin glycoprotein | MIM:164345 | Ensembl:ENSG00000126861 | HGNC:HGNC:8135 | PA31922 | 17q11.2 |
Gene Categories:
DRUGGABLE GENOMEGO terms in OMG
Term Type | Evidence Type | GO Term ID | GO Des. |
---|---|---|---|
BP | IEA | GO:0007155 | cell adhesion |
BP | TAS | GO:0050771 | negative regulation of axonogenesis |
CC | TAS | GO:0005886 | plasma membrane |
CC | IEA | GO:0031225 | anchored component of membrane |
Gene expression in normal tissue: OMG
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in OMG
Database | Pathway ID | Pathway Des. |
---|---|---|
wikipathways | WP2431 | Spinal Cord Injury |
pid | p75ntrpathway | p75(NTR)-mediated signaling |
reactome | R-HSA-162582 | Signal Transduction |
reactome | R-HSA-193634 | Axonal growth inhibition (RHOA activation) |
reactome | R-HSA-193697 | p75NTR regulates axonogenesis |
reactome | R-HSA-193704 | p75 NTR receptor-mediated signalling |
reactome | R-HSA-73887 | Death Receptor Signalling |
Gene-Drug: Aster Plot
Drug ID | Drug Name | Model Num. |
---|---|---|
iGMDRD286 | Nsc 632839 | 5 |
iGMDRD414 | MST-312 | 5 |
iGMDRD188 | Piperlongumine | 5 |
iGMDRD100 | Zebularine | 5 |
iGMDRD505 | Pevonedistat | 2 |
iGMDRD886 | Compound 1541A | 2 |
iGMDRD60 | Quinoclamine | 2 |
iGMDRD263 | AACOCF3 | 1 |
iGMDRD322 | FK 866 | 2 |
iGMDRD103 | SN-38 | 4 |
iGMDRD121 | GMX1778 | 2 |
iGMDRD138 | PX 12 | 3 |
iGMDRD251 | ML162 | 2 |
iGMDRD802 | 4-methylfasudil | 1 |
iGMDRD255 | SB225002 | 3 |
iGMDRD446 | LY 2183240 | 3 |
iGMDRD142 | NSC74859 | 1 |
iGMDRD152 | 179324-69-7 | 2 |
iGMDRD61 | Kinetin riboside | 3 |
iGMDRD297 | Austocystin D | 5 |
iGMDRD116 | CD437 | 3 |
iGMDRD144 | NSC95397 | 5 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in OMG